States on the Front Line: Addressing America's Drug Pricing Problem
- PMID: 31503529
- DOI: 10.1080/01947648.2019.1645544
States on the Front Line: Addressing America's Drug Pricing Problem
Similar articles
-
Pharmaceuticals and medical devices: Medicare Part D. End-of-year issue brief.Issue Brief Health Policy Track Serv. 2009 Jan 5:1-26. Issue Brief Health Policy Track Serv. 2009. PMID: 19301435 No abstract available.
-
Value-Based Pricing and State Reform of Prescription Drug Costs.JAMA. 2017 Aug 15;318(7):609-610. doi: 10.1001/jama.2017.8255. JAMA. 2017. PMID: 28692713 No abstract available.
-
The Burden of Federalism: Challenges to State Attempts at Controlling Prescription Drug Costs.J Leg Med. 2019 Apr-Jun;39(2):95-120. doi: 10.1080/01947648.2019.1645541. J Leg Med. 2019. PMID: 31503534 No abstract available.
-
Pharmaceutical costs. An overview and analysis of legal and policy responses by the states.J Leg Med. 2003 Jun;24(2):141-73. doi: 10.1080/713832157. J Leg Med. 2003. PMID: 12775406 Review. No abstract available.
-
AMCP Guide to Pharmaceutical Payment Methods, 2009 Update (Version 2.0).J Manag Care Pharm. 2009 Aug;15(6 Suppl A):S3-57, quiz S58-61. doi: 10.18553/jmcp.2009.15.s6-a.1. J Manag Care Pharm. 2009. PMID: 19678720 Free PMC article. Review.
Cited by
-
Characteristics of State Legislation Addressing Prescription Drug Price Increases in the United States, 2020.J Gen Intern Med. 2022 May;37(6):1554-1557. doi: 10.1007/s11606-021-06838-x. Epub 2021 May 28. J Gen Intern Med. 2022. PMID: 34047918 Free PMC article. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources